Bio-Rad Laboratories | BIO - 当期純利益





当期純利益 変化する 日付
Abbott USD 1.08B 699M 2026-03
Agilent USD 339M 34M 2026-03
Becton, Dickinson and Co. USD -311M 693M 2026-03
Bio Techne USD 51.05M 13.04M 2026-03
Bio-Rad Laboratories USD 720M 1.06B 2025-12
Bruker USD 3.5M 22.5M 2026-03
Charles River Laboratories USD -14.84M 261.71M 2026-03
Danaher USD 1.03B 168M 2026-03
General Electric Aerospace USD 1.9B 637M 2026-03
Illumina USD 134M 200M 2026-03
IQVIA Holdings USD 274M 240M 2026-03
Laboratory Of America USD 277.8M 113.1M 2026-03
Merck USD -4.24B 7.2B 2026-03
Mettler Toledo International USD 169.45M 116.31M 2026-03
Myriad Genetics USD -7.9M 19.5M 2025-12
OraSure Technologies USD -19.29M 5.57M 2025-12
Pacific Biosciences Of California USD -40.37M 2.37M 2025-12
Quest Diagnostics USD 251M 6M 2026-03
Repligen USD 8.33M 4.95M 2026-03
Revvity USD 40.72M 57.65M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Siemens EUR 2.03B 3M 2026-03
Standard Biotools USD 19.28M 53.97M 2025-12
Thermo Fisher Scientific USD 1.65B 313M 2026-03
Tosoh JPY 16.99B 266M 2026-03
Waters USD -72M 297.21M 2026-03